Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Genome Biologics

Start a request
Year Established:
2016
Website:
genomebiologics.com
Headquarters:
Frankfurt am Main, Hessen, DE
Company Type:
Mid-Sized Business (10-100M TTM Revenue)
Completed Requests:
2
Open Requests:
1

Genome Biologics is leaders in therapeutic target discovery and RNA-targeted therapies in Cardiovascular Disease.

We have developed a seamless integrated platform that directly couples the output of complex AI-driven human disease genetic analysis – GENIMAPS – to the capacity to model the disease heterogeneity– directly in ex vivo patient-derived heart tissue TrueCardium AND in small and large animals with our patented GENISYST technology.

Through application of our integrated technologies – we are Increasing the physiological accuracy and relevance of preclinical drug development and at the same time reducing discovery time and cost. As a platform output, we have developed a rich therapeutic pipeline for Heart Failure, CHIP, Cardiotoxicity and rare disease. We aim to initiate Phase 1 studies with our lead compound in 2022.

Site Badges
Genome Biologics UG
Institute of Cardiovascular Regeneration, Centre for Molecular Medicine, Building 25B, 5th floor Frankfurt am Main, Hessen, 60590 Germany
Address
Institute of Cardiovascular Regeneration, Centre for Molecular Medicine, Building 25B, 5th floor Frankfurt am Main, Hessen, 60590 Germany

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service